Skip to main content

Optimizing market access

How therapeutic area dynamics could influence strategy

With public pressure to reduce drug spending, payers are increasingly using formulary tools to help manage market access. This article examines market factors driving market access strategies in different therapeutic areas.

 

Market access strategy is complex, dynamic, and constantly evolving. Over the last several years, payers have increasingly used formulary tiering as one tool to help control and manage market access. With intensifying public pressure to reduce drug spending, this trend is likely to continue.

Optimizing market access requires an understanding of how payers might leverage tools differently among therapeutic or disease areas or across segments. Market access leaders should make decisions around what strategies to prioritize and implement in this context.

In the report, we explore several different strategies drug manufacturers can leverage to influence or make the best of formulary positioning.

Did you find this useful?

Thanks for your feedback

If you would like to help improve Deloitte.com further, please complete a 3-minute survey